Conditional Cash Transfers to Incentivize Tuberculosis Screening: Description of a Novel Strategy for Contact Investigation in Rural South Africa.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
23 03 2022
Historique:
received: 03 02 2021
pubmed: 3 7 2021
medline: 6 5 2022
entrez: 2 7 2021
Statut: ppublish

Résumé

Providing incentives to screen close contacts for tuberculosis (TB) is an alternative to household-based contact investigation. We aimed to characterize patients and contexts where this incentive-based strategy might be preferred. This is a secondary analysis of a cluster randomized trial of TB contact investigation in Limpopo District, South Africa, conducted between 2016 and 2020. Twenty-eight clinics were randomly allocated to household-based vs incentive-based contact investigation. In the incentive-based arm, index participants and contacts received transport reimbursement and incentives for TB screening and microbiological diagnosis of contacts. We estimated differences in mean number of contacts per index participant with household-based vs incentive-based contact investigation overall and within subgroups of index participants. A total of 3776 contacts (1903 in the incentive-based and 1873 in the household-based arm) were referred by 2501 index participants. A higher proportion of contacts in the incentive-based than household-based arm were adults (72% vs 59%), reported chronic TB symptoms (25% vs 16%) or ever smoking (23% vs 11%). Index participants who walked or bicycled to a clinic referred 1.03 more contacts per index (95% confidence interval [CI], .48 to 1.57) through incentive-based than household-based investigation. Index participants living with >5 household members referred 0.48 more contacts per index (95% CI, .03 to .94) through household-based than incentive-based investigation. Relative to household-based investigation, incentive-based investigation identifies contacts likely at higher risk for active TB. Incentive-based investigation may be more appropriate for index participants who can easily access clinics, versus household-based investigation for patients with large households. Clinical Trials Registration. NCT02808507.

Sections du résumé

BACKGROUND
Providing incentives to screen close contacts for tuberculosis (TB) is an alternative to household-based contact investigation. We aimed to characterize patients and contexts where this incentive-based strategy might be preferred.
METHODS
This is a secondary analysis of a cluster randomized trial of TB contact investigation in Limpopo District, South Africa, conducted between 2016 and 2020. Twenty-eight clinics were randomly allocated to household-based vs incentive-based contact investigation. In the incentive-based arm, index participants and contacts received transport reimbursement and incentives for TB screening and microbiological diagnosis of contacts. We estimated differences in mean number of contacts per index participant with household-based vs incentive-based contact investigation overall and within subgroups of index participants.
RESULTS
A total of 3776 contacts (1903 in the incentive-based and 1873 in the household-based arm) were referred by 2501 index participants. A higher proportion of contacts in the incentive-based than household-based arm were adults (72% vs 59%), reported chronic TB symptoms (25% vs 16%) or ever smoking (23% vs 11%). Index participants who walked or bicycled to a clinic referred 1.03 more contacts per index (95% confidence interval [CI], .48 to 1.57) through incentive-based than household-based investigation. Index participants living with >5 household members referred 0.48 more contacts per index (95% CI, .03 to .94) through household-based than incentive-based investigation.
CONCLUSIONS
Relative to household-based investigation, incentive-based investigation identifies contacts likely at higher risk for active TB. Incentive-based investigation may be more appropriate for index participants who can easily access clinics, versus household-based investigation for patients with large households. Clinical Trials Registration. NCT02808507.

Identifiants

pubmed: 34212181
pii: 6312933
doi: 10.1093/cid/ciab601
pmc: PMC8946721
doi:

Banques de données

ClinicalTrials.gov
['NCT02808507']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

957-964

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL151977
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116787
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI147681
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Implement Sci. 2017 Mar 9;12(1):33
pubmed: 28274245
Cochrane Database Syst Rev. 2015 Sep 03;(9):CD007952
pubmed: 26333525
Respirology. 2018 Jun 5;:
pubmed: 29869818
PLoS Med. 2016 Sep 06;13(9):e1002119
pubmed: 27598345
J Infect Dis Med. 2018;3(1):
pubmed: 29707699
PLoS One. 2012;7(6):e39246
pubmed: 22768066
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710
BMC Infect Dis. 2015 Feb 26;15:103
pubmed: 25886411
Lancet Infect Dis. 2016 Nov;16(11):1269-1278
pubmed: 27522233
BMC Infect Dis. 2019 Oct 12;19(1):839
pubmed: 31606032
Lancet. 2004 Jan 17;363(9404):212-4
pubmed: 14738796
PLoS Med. 2019 Apr 30;16(4):e1002796
pubmed: 31039165
Annu Rev Public Health. 2013;34:431-47
pubmed: 23297657

Auteurs

Yeonsoo Baik (Y)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Colleen F Hanrahan (CF)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Lesego Mmolawa (L)

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Bareng A S Nonyane (BAS)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Nicholas W Albaugh (NW)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Limakatso Lebina (L)

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Tsundzukani Siwelana (T)

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Neil Martinson (N)

Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

David W Dowdy (DW)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH